Progress of prevention and cure of chemoradiotherapy-related hepatitis B virus reactivation
10.3760/cma.j.issn.1673-422X.2014.03.007
- VernacularTitle:恶性肿瘤放化疗致乙型肝炎病毒再激活防治进展
- Author:
Mengsen WANG
;
Yonghua YU
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Virus activation;
Neoplasms;
Drug therapy;
Radiotherapy
- From:
Journal of International Oncology
2014;41(3):184-187
- CountryChina
- Language:Chinese
-
Abstract:
Reactivation of hepatitis B virus (HBV) in cancer patients with HBV infection during or after chemoradiotherapy can lead to acute liver injury,even death.Antiviral prophylaxis can reduce the occurrence of HBV reactivation and its associated morbidity.However,there is no unified standard to guide antiviral treatment.Therefore,multidisciplinary collaboration and more prospective study should be carried out to identify the individual antiviral treatment plan.
